These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
8. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H. Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [Abstract] [Full Text] [Related]
9. [New drugs against tuberculosis and nontuberculous mycobacterial infections: a review]. Amitani R, Kuze F. Kekkaku; 1994 Nov; 69(11):711-7. PubMed ID: 7837725 [Abstract] [Full Text] [Related]
10. [Non-tuberculous mycobacteriosis. What has been coming out]. Kajiki A. Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655 [Abstract] [Full Text] [Related]
14. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Tomioka H, Sato K, Saito H. Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119 [Abstract] [Full Text] [Related]
20. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy]. Shigeto E, Murakami I, Yokosaki Y. Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]